Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Gross Profit (2020 - 2025)

Historic Gross Profit for Neuroone Medical Technologies (NMTC) over the last 10 years, with Q4 2025 value amounting to $1.6 million.

  • Neuroone Medical Technologies' Gross Profit fell 1863.42% to $1.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $4.8 million, marking a year-over-year increase of 7452.27%. This contributed to the annual value of $5.1 million for FY2025, which is 37620.29% up from last year.
  • Neuroone Medical Technologies' Gross Profit amounted to $1.6 million in Q4 2025, which was down 1863.42% from $1.5 million recorded in Q3 2025.
  • Over the past 5 years, Neuroone Medical Technologies' Gross Profit peaked at $1.9 million during Q4 2024, and registered a low of -$36223.0 during Q1 2022.
  • Moreover, its 5-year median value for Gross Profit was $167358.5 (2023), whereas its average is $405726.6.
  • In the last 5 years, Neuroone Medical Technologies' Gross Profit crashed by 7148.61% in 2022 and then surged by 389956.34% in 2023.
  • Quarter analysis of 5 years shows Neuroone Medical Technologies' Gross Profit stood at -$13096.0 in 2021, then grew by 6.02% to -$12307.0 in 2022, then skyrocketed by 2263.92% to $266314.0 in 2023, then soared by 623.54% to $1.9 million in 2024, then dropped by 18.63% to $1.6 million in 2025.
  • Its last three reported values are $1.6 million in Q4 2025, $1.5 million for Q3 2025, and $914835.0 during Q2 2025.